HealthNotableConfirmed
5.6
Thailand restricts weight-loss pens to prescription-only amid black-market GLP-1 glut
South China Morning PostLO·TH·3 days ago
Novo Nordisk faces shareholder pressure to diversify beyond its GLP-1 franchise as competition intensifies. The company is expected to address dealmaking strategy and pipeline gaps at its upcoming shareholder meeting. This signals potential strategic shifts that could impact the company's growth outlook and sector positioning.